Sonova Buys InSound, Eyes Lyric Hearing Aid Sales Of $300 Mil. By 2015
This article was originally published in The Gray Sheet
Executive Summary
Swiss hearing aid maker Sonova expects sales of its newly acquired Lyric "invisible" hearing aid to reach $200 million to $300 million by 2015. The firm acquired Lyric developer InSound Medical on Jan. 6 for $75 million, plus milestone payments
You may also be interested in...
News In Brief
Mela Sciences’ MelaFind PMA amendment
News In Brief
Mela Sciences’ MelaFind PMA amendment
A Boom in Devices for the Hearing Impaired
Competition is spurring innovation in the hearing aid market and providers are excited at the prospect of adopting new products that can improve on existing treatments. The hottest area at the moment is implantable hearing aid devices. It's not a new concept, but it's one that many believe will command a significant share of the market.